334 results on '"McAleese, J."'
Search Results
2. The Association of Incidental Radiation Dose to the Heart Base with Overall Survival and Cardiac Events after Curative-intent Radiotherapy for Non-small Cell Lung Cancer: Results from the NI-HEART Study
3. Assessment of the Implementation of Lung Cancer Consensus Statements From the Royal College of Radiologists in 2021; Progress and Barriers
4. Reducing the Risk of Death From Pneumocystis jirovecii Pneumonia After Radical Radiation Therapy to the Lung
5. Service improvements and workload increases; Royal College of Radiologists (RCR) re-audit of curative intent radiotherapy for non-small cell lung cancer (NSCLC)
6. Neutrophil–Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Patients Treated with Curative-intent Radiotherapy for Non-small Cell Lung Cancer
7. Predicting the Risk of Disease Recurrence and Death Following Curative-intent Radiotherapy for Non-small Cell Lung Cancer: The Development and Validation of Two Scoring Systems From a Large Multicentre UK Cohort
8. Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis
9. Bedside physician led US-guided supra-clavicular lymph node biopsy and ROSE (rapid on-site evaluation): SVC obstruction swift management in lung cancer
10. Differential Relapse Patterns for Non-small Cell Lung Cancer Subtypes Adenocarcinoma and Squamous Cell Carcinoma: Implications for Radiation Oncology
11. Patient-Level and Endpoint-Specific Clinico-Dosimetric Analysis of the Cardiac Base as a Mediator of Radiation Cardiotoxicity in Non-Small Cell Lung Cancer
12. Simulation CT Features and Radiation Cardiotoxicity in Non-Small Cell Lung Cancer
13. Re-irradiation for Locally Recurrent Lung Cancer: Evidence, Risks and Benefits
14. The Elderly are Less Likely to Receive Recommended Radical Radiotherapy for Non-small Cell Lung Cancer
15. Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study
16. The Impact of Colleague Peer Review on the Radiotherapy Treatment Planning Process in the Radical Treatment of Lung Cancer
17. The Quality of Curative-intent Radiotherapy for Non-small Cell Lung Cancer in the UK
18. EP04.02-002 International Consensus on Actions to Improve Lung Cancer Survival: Delphi Method in the International Cancer Benchmarking Partnership
19. Investigating the Potential Impact of Four-dimensional Computed Tomography (4DCT) on Toxicity, Outcomes and Dose Escalation for Radical Lung Cancer Radiotherapy
20. 196P An international consensus on actions to improve lung cancer survival: A clinical review by the international cancer benchmarking partnership (ICBP)
21. PH-0274 NLR & ALC as prognostic markers in patients treated with curative intent radiotherapy for NSCLC
22. PET/CT features of lung SABR chest wall toxicity
23. Early circulating tumour DNA kinetics measured by ultra-deep next-generation sequencing during radical radiotherapy for non-small cell lung cancer: a feasibility study
24. Re: Lewis et al. Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?
25. PD-0323 A pulmonary vein atlas for radiotherapy planning
26. PD-0159 Association of Statin Intensity With Cardiac Events and Mortality After Radiotherapy for NSCLC
27. Re: Mercieca et al. Implementing the Royal College of Radiologists' Radiotherapy Target Volume Definition and Peer Review Guidelines: More Still to Do?
28. Improvements in survival with a more aggressive departmental approach to radiotherapy in locally advanced NSCLC
29. Neutrophil lymphocyte ratio as a prognostic marker in patients treated with curative intent radiotherapy for non-small cell lung cancer
30. Investigating the cause of early death after radical lung radiotherapy
31. Oligometastases in extensive disease-small cell lung cancer
32. Oligometastatic relapse after radical radiotherapy for NSCLC
33. Curative Radiotherapy for Lung Cancer in the UK: International Benchmarking
34. P2.01-25 TOURIST: Thoracic Umbrella Radiotherapy Study in Stage IV NSCLC: A Phase III Randomized Trial in Development
35. Radical radiotherapy alone versus chemoradiotherapy for the treatment of stage III (N2) non-small cell lung cancer
36. Survival following radical radiotherapy for satellite or synchronous ipsilateral nodules
37. Risk of Death from Pneumocystis jirovecii after Curative-intent Radiotherapy for Lung Cancer
38. P1.17-12 Colleague Peer Review of Radical Lung Radiotherapy Treatment Plans: The Impact on Interval from Decision to Treat to Treatment Delivery
39. OA13.01 The Impact of [18F]fludeoxyglucose PET/CT in Small-Cell Lung Cancer: Analysis of the Phase 3 CONVERT Trial
40. P3.17-19 First Relapse and Survival Five Years After Radical Radiotherapy for Lung Cancer
41. P3.16-18 Modern Radiotherapy Increases Patient Access to Curative Intent Radiotherapy in Non-Small Cell Lung Cancer
42. Interstitial Lung Disease and Curative Lung Radiotherapy; Increased Risk of Mortality
43. Curative Radiotherapy for Patients with Lung Cancer; What is the Appropriate Number to Treat?
44. Referrals Patterns to an Oncology Clinical Advice Service
45. EP-1398: Isolated Nodal Failure rates following curative intent radiotherapy in a modern cohort
46. Rate of marginal relapse following curative intent radiotherapy in a modern cohort
47. Curative radiotherapy for non-small cell lung cancer in the UK: international benchmarking
48. 30-day SACT mortality at Antrim Hospital Lung and Uro-Oncology Unit clinic, Northern Trust
49. Consultant-led peer review for lung cancer; system-based or individual-based variances?
50. Northern Ireland brain metastases radiotherapy audit
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.